annual retained earnings:
$20.15B+$4.59B(+29.47%)Summary
- As of today (April 16, 2025), NVO annual retained earnings is $20.15 billion, with the most recent change of +$4.59 billion (+29.47%) on December 31, 2024.
- During the last 3 years, NVO annual retained earnings has risen by +$9.19 billion (+83.85%).
- NVO annual retained earnings is now at all-time high.
Performance
NVO Retained earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly retained earnings:
$20.15B+$1.93B(+10.58%)Summary
- As of today (April 16, 2025), NVO quarterly retained earnings is $20.15 billion, with the most recent change of +$1.93 billion (+10.58%) on December 31, 2024.
- Over the past year, NVO quarterly retained earnings has increased by +$4.05 billion (+25.18%).
- NVO quarterly retained earnings is now at all-time high.
Performance
NVO quarterly retained earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Retained earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
NVO Retained earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +29.5% | +25.2% |
| 3 y3 years | +83.8% | +83.8% |
| 5 y5 years | +132.5% | +132.5% |
NVO Retained earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +83.8% | at high | +107.0% |
| 5 y | 5-year | at high | +132.5% | at high | +148.8% |
| alltime | all time | at high | +9551.4% | at high | +9551.4% |
Novo Nordisk A/S Retained earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $20.15B(+29.5%) | $20.15B(+10.6%) |
| Sep 2024 | - | $18.22B(+13.2%) |
| Jun 2024 | - | $16.10B(+12.4%) |
| Mar 2024 | - | $14.33B(-8.0%) |
| Dec 2023 | $15.57B(+34.2%) | $15.57B(+19.8%) |
| Sep 2023 | - | $12.99B(+1.0%) |
| Jun 2023 | - | $12.86B(+14.0%) |
| Mar 2023 | - | $11.28B(-2.7%) |
| Dec 2022 | $11.60B(+5.8%) | $11.60B(+19.1%) |
| Sep 2022 | - | $9.74B(-5.2%) |
| Jun 2022 | - | $10.27B(+2.8%) |
| Mar 2022 | - | $10.00B(-8.8%) |
| Dec 2021 | $10.96B(+4.0%) | $10.96B(+3.5%) |
| Sep 2021 | - | $10.60B(-1.4%) |
| Jun 2021 | - | $10.75B(+13.1%) |
| Mar 2021 | - | $9.50B(-9.8%) |
| Dec 2020 | $10.54B(+21.6%) | $10.54B(+11.7%) |
| Sep 2020 | - | $9.44B(+4.2%) |
| Jun 2020 | - | $9.05B(+11.8%) |
| Mar 2020 | - | $8.10B(-6.5%) |
| Dec 2019 | $8.67B(+5.9%) | $8.67B(+10.1%) |
| Sep 2019 | - | $7.87B(-3.5%) |
| Jun 2019 | - | $8.16B(+11.8%) |
| Mar 2019 | - | $7.30B(-10.8%) |
| Dec 2018 | $8.18B(+3.7%) | $8.18B(+7.3%) |
| Sep 2018 | - | $7.62B(-3.0%) |
| Jun 2018 | - | $7.86B(+8.9%) |
| Mar 2018 | - | $7.22B(-8.6%) |
| Dec 2017 | $7.89B(+20.4%) | $7.89B(+10.2%) |
| Sep 2017 | - | $7.16B(-0.9%) |
| Jun 2017 | - | $7.23B(+23.6%) |
| Mar 2017 | - | $5.85B(-10.8%) |
| Dec 2016 | $6.56B(-4.4%) | $6.56B(+6.1%) |
| Sep 2016 | - | $6.18B(-2.8%) |
| Jun 2016 | - | $6.36B(+15.9%) |
| Mar 2016 | - | $5.48B(-20.0%) |
| Dec 2015 | $6.86B(+1.8%) | $6.86B(+6.2%) |
| Sep 2015 | - | $6.46B(+9.1%) |
| Jun 2015 | - | $5.92B(+17.3%) |
| Mar 2015 | - | $5.04B(-25.2%) |
| Dec 2014 | $6.74B(-11.5%) | $6.74B(+2.0%) |
| Sep 2014 | - | $6.60B(-0.0%) |
| Jun 2014 | - | $6.61B(+10.8%) |
| Mar 2014 | - | $5.96B(-21.7%) |
| Dec 2013 | $7.61B(+10.1%) | $7.61B(+11.3%) |
| Sep 2013 | - | $6.84B(+14.7%) |
| Jun 2013 | - | $5.96B(+6.7%) |
| Mar 2013 | - | $5.59B(-19.2%) |
| Dec 2012 | $6.91B(+6.9%) | $6.91B(+15.4%) |
| Sep 2012 | - | $5.99B(+16.1%) |
| Jun 2012 | - | $5.16B(-7.8%) |
| Mar 2012 | - | $5.60B(-13.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $6.47B(+0.4%) | $6.47B(+1.7%) |
| Sep 2011 | - | $6.36B(-7.5%) |
| Jun 2011 | - | $6.88B(+9.2%) |
| Mar 2011 | - | $6.30B(-2.2%) |
| Dec 2010 | $6.44B(-2.8%) | $6.44B(+4.6%) |
| Sep 2010 | - | $6.16B(+13.5%) |
| Jun 2010 | - | $5.43B(-7.5%) |
| Mar 2010 | - | $5.86B(-11.5%) |
| Dec 2009 | $6.62B(+5.3%) | $6.62B(+0.3%) |
| Sep 2009 | - | $6.60B(+5.0%) |
| Jun 2009 | - | $6.29B(+11.6%) |
| Mar 2009 | - | $5.63B(-10.4%) |
| Dec 2008 | $6.29B(+4.8%) | $6.29B(+4.3%) |
| Sep 2008 | - | $6.03B(-8.4%) |
| Jun 2008 | - | $6.58B(+5.7%) |
| Mar 2008 | - | $6.23B(+3.7%) |
| Dec 2007 | $6.00B(+17.8%) | $6.00B(-1.1%) |
| Sep 2007 | - | $6.07B(+3.9%) |
| Jun 2007 | - | $5.84B(+14.6%) |
| Mar 2007 | - | $5.10B(-0.0%) |
| Dec 2006 | $5.10B(+19.3%) | $5.10B(+11.0%) |
| Sep 2006 | - | $4.59B(-2.7%) |
| Jun 2006 | - | $4.72B(+12.0%) |
| Mar 2006 | - | $4.21B(-1.4%) |
| Dec 2005 | $4.27B(+2.8%) | $4.27B(+2.3%) |
| Sep 2005 | - | $4.18B(+2.7%) |
| Jun 2005 | - | $4.07B(-5.8%) |
| Mar 2005 | - | $4.32B(+3.9%) |
| Dec 2004 | $4.16B(+16.2%) | $4.16B(+12.3%) |
| Sep 2004 | - | $3.70B(+4.8%) |
| Jun 2004 | - | $3.53B(+4.1%) |
| Mar 2004 | - | $3.39B(-5.2%) |
| Dec 2003 | $3.58B(+33.2%) | $3.58B(+33.2%) |
| Dec 2002 | $2.69B(+38.1%) | $2.69B(+38.1%) |
| Dec 2001 | $1.95B(+26.3%) | $1.95B(+26.3%) |
| Dec 2000 | $1.54B(-2.4%) | $1.54B(-2.4%) |
| Dec 1999 | $1.58B(-30.3%) | $1.58B(-30.3%) |
| Dec 1998 | $2.26B(+5.8%) | $2.26B(+5.8%) |
| Dec 1997 | $2.14B(+0.9%) | $2.14B(+0.9%) |
| Dec 1996 | $2.12B(+6.9%) | $2.12B(+6.9%) |
| Dec 1995 | $1.98B(+24.0%) | $1.98B(+24.0%) |
| Dec 1994 | $1.60B(+26.8%) | $1.60B(+26.8%) |
| Dec 1993 | $1.26B(+10.2%) | $1.26B(+10.2%) |
| Dec 1992 | $1.15B(+10.5%) | $1.15B(+10.5%) |
| Dec 1991 | $1.04B(+23.9%) | $1.04B(+23.9%) |
| Dec 1990 | $836.53M(+36.4%) | $836.53M(+36.4%) |
| Dec 1989 | $613.38M(+22.0%) | $613.38M(+22.0%) |
| Dec 1988 | $502.64M(-1.5%) | $502.64M(-1.5%) |
| Dec 1987 | $510.48M(+30.1%) | $510.48M(+30.1%) |
| Dec 1986 | $392.49M(+22.7%) | $392.49M(+22.7%) |
| Dec 1985 | $319.90M(+53.2%) | $319.90M(+53.2%) |
| Dec 1984 | $208.81M | $208.81M |
FAQ
- What is Novo Nordisk A/S annual retained earnings?
- What is the all time high annual retained earnings for Novo Nordisk A/S?
- What is Novo Nordisk A/S annual retained earnings year-on-year change?
- What is Novo Nordisk A/S quarterly retained earnings?
- What is the all time high quarterly retained earnings for Novo Nordisk A/S?
- What is Novo Nordisk A/S quarterly retained earnings year-on-year change?
What is Novo Nordisk A/S annual retained earnings?
The current annual retained earnings of NVO is $20.15B
What is the all time high annual retained earnings for Novo Nordisk A/S?
Novo Nordisk A/S all-time high annual retained earnings is $20.15B
What is Novo Nordisk A/S annual retained earnings year-on-year change?
Over the past year, NVO annual retained earnings has changed by +$4.59B (+29.47%)
What is Novo Nordisk A/S quarterly retained earnings?
The current quarterly retained earnings of NVO is $20.15B
What is the all time high quarterly retained earnings for Novo Nordisk A/S?
Novo Nordisk A/S all-time high quarterly retained earnings is $20.15B
What is Novo Nordisk A/S quarterly retained earnings year-on-year change?
Over the past year, NVO quarterly retained earnings has changed by +$4.05B (+25.18%)